GoodRx Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 5, 2026, announces the financial results for GoodRx Holdings, Inc. for the three and six months ended June 30, 2026. The full details of the results are contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this excerpt. Investors must refer to Exhibit 99.1 for these figures.
Material Changes
The filing text does not disclose specific material changes or comparative performance metrics versus prior periods. Such information is referenced as being available in the accompanying press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. These disclosures are contained within the press release referenced in Item 2.02.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended June 30, 2026.
- Verify year-over-year and quarter-over-quarter growth rates in the full press release.
- Check for any updated financial guidance or strategic outlook provided in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.